Division of Electrophysiology, Department of Cardiology, Herlev-Gentofte Hospital, Gentofte Hospitalsvej 1, DK-2900, Hellerup, Denmark.
J Interv Card Electrophysiol. 2024 Jan;67(1):99-109. doi: 10.1007/s10840-023-01570-4. Epub 2023 May 30.
Focal pulsed field ablation (FPFA) is a novel and promising method of cardiac ablation. The aim of this study was to report the feasibility, short-term safety, and procedural findings for a broad spectrum of ablated atrial arrhythmias.
Patients (n = 51) scheduled for ablation of atrial arrhythmias were prospectively included and underwent FPFA using the Galvanize CENTAURI generator with energy delivery through commercially available ablation catheters with ultrahigh-density (UHDx) 3D electroanatomic voltage/local activation time map evaluations. Workflow, procedural data, and peri-procedural technical errors and complications are described.
Planned ablation strategy was achieved with FPFA-only in 48/51 (94%) of the cases. Ablation strategy was first-time pulmonary vein isolation (PVI) in 17/51 (36%), repeat ablation in 18/51 (38%), PVI + in 13/51 (28%), and cavotricuspid isthmus block (CTI)-only in 3/51 (6%). The mean procedure time was 104 ± 31 min (first-time PVI), 114 ± 26 min (repeat procedure), 152 ± 36 min (PVI +), and 62 ± 17 min (CTI). Mean UHDx mapping time to assess lesion formation and block after ablation was 7 ± 4 min with 5485 ± 4809 points. First pass acute (linear) isolation with bidirectional block for anatomical lesion sets was 120/124 (97%) for all PVs, 17/17 (100%) for (any) isthmus, and 14/17 (82%) for left atrium posterior wall (LAPW). We observed several time-consuming integration errors with the used ablation system (mean 3.4 ± 3.7 errors/procedure), one transient inferior ST elevation when ablating CTI resolved by intravenous nitroglycerine and one transient AV block requiring temporary pacing for > 24 h.
FPFA was a highly versatile method to treat atrial arrhythmias with high first-pass efficiency. UHDx revealed acute homogenous low-voltage lesions in ablated areas. More data is needed to establish lesion durability and limitations of FPFA.
聚焦脉冲场消融(FPFA)是一种新颖且有前途的心脏消融方法。本研究旨在报告广泛消融的房性心律失常的可行性、短期安全性和程序发现。
前瞻性纳入计划行消融治疗的房性心律失常患者,并使用 Galvanize CENTAURI 发生器进行 FPFA,通过市售的具有超高密度(UHDx)3D 电激动/电压时间图评估的消融导管进行能量传递。描述工作流程、程序数据以及围手术期技术错误和并发症。
48/51(94%)例患者仅通过 FPFA 实现了计划消融策略。消融策略为首次肺静脉隔离(PVI)的有 17/51(36%)例,重复消融的有 18/51(38%)例,PVI+的有 13/51(28%)例,单纯行三尖瓣峡部阻滞(CTI)的有 3/51(6%)例。平均手术时间为首次 PVI 的 104±31 分钟,重复手术的 114±26 分钟,PVI+的 152±36 分钟,CTI 的 62±17 分钟。消融后评估病变形成和阻滞的 UHDx 平均映射时间为 7±4 分钟,有 5485±4809 个点。首次通过线性双向阻滞对解剖病变组进行急性(线性)隔离,所有肺静脉的 120/124 个(97%),任何峡部的 17/17 个(100%),左心房后壁(LAPW)的 14/17 个(82%)。我们观察到使用的消融系统存在一些耗时的整合错误(平均每个手术 3.4±3.7 个错误),在消融 CTI 时出现一过性下壁 ST 段抬高,经静脉给予硝酸甘油缓解,一过性房室传导阻滞需要临时起搏超过 24 小时。
FPFA 是一种治疗房性心律失常的多功能方法,首次通过效率高。UHDx 显示了消融区域的急性均匀低电压病变。需要更多的数据来确定 FPFA 的病变耐久性和局限性。